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A B S T R A C T
Objectives: Dialysis patients report a low health-related quality of life (HRQOL) due to high disease burden
and far-reaching consequences of dialysis treatment. This study examined several cognitive-behavioral
and social factors, with a focus on negative outcome expectancies, that might be relevant for HRQOL in
end-stage kidney disease (ESKD) patients treated with dialysis.
Methods: Patients treated with hemodialysis or peritoneal dialysis were recruited from Dutch hospitals
and dialysis centers. Patients completed self-report questionnaires at baseline (n = 175) and six months
follow-up (n = 130). Multiple regression analyses were performed.
Results: Higher scores on factors related to negative outcome expectancies at baseline, especially
helplessness and worrying, and less perceived social support were significantly related to worse HRQOL
six months later. When controlling for baseline HRQOL, besides sex and comorbidity, helplessness
remained significantly predictive of worse HRQOL six months later, indicating that helplessness is
associated with changes in HRQOL over time.
Conclusions: Negative outcome expectancies and social support are relevant markers for HRQOL and/or
changes in HRQOL over time.
Practice implications: Negative outcome expectancies could be prevented or diminished by enhanced
treatment information, an improved patient-clinician relationship, and interventions that promote
adaptive and realistic expectations. Additionally, increasing supportive social relationships could be a
relevant treatment focus.
© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
End-stage kidney disease (ESKD) is the last stage of chronic
kidney disease, which has a large impact on patients’ lives as it
affects patients’ physical, psychological, as well as social well-
being [1,2]. In patients with ESKD, kidney function has declined to
15 percent of normal functioning. In order to stay alive, patients
need a kidney transplant or dialysis treatment to replace kidney
function. In the United States, over 700,000 patients receive
treatment for ESKD, giving a point prevalence of 2,206 per million
population [3]. Most of them are treated with hemodialysis (HD)
three times per week. In HD, a machine is used to clean the blood.
Peritoneal dialysis (PD) is another type of dialysis treatment which
needs to be repeated four to six times a day. In PD, the inside lining
of the abdominal cavity (peritoneum) is used as a natural filter [4].
Although the specific consequences differ per dialysis type, dialysis
is a highly intrusive and demanding treatment [5].
Many dialysis patients experience disabilities and suffer from
various problems, such as fatigue, itch, pain, depression, anxiety,
social difficulties, and a decreased sense of independence [6–9].
Not surprisingly, patients’ quality of life is remarkably lower than
that of the general population [10,11]. Moreover, health-related
quality of life (HRQOL) is associated with morbidity and mortality
in dialysis patients [11]. Clinical characteristics (e.g., comorbidity,
* Corresponding author.
E-mail addresses: j.tommel@fsw.leidenuniv.nl (J. Tommel),
a.evers@fsw.leidenuniv.nl (A.W.M. Evers), Henk.vanHamersvelt@radboudumc.nl
(H.W. van Hamersvelt), erienjordens@gmail.com (R. Jordens),
SDijk@FSW.leidenuniv.nl (S. van Dijk), Luuk.Hilbrands@radboudumc.nl
(L.B. Hilbrands), h.vanmiddendorp@fsw.leidenuniv.nl (H. van Middendorp).
https://doi.org/10.1016/j.pec.2020.11.019
0738-3991/© 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Patient Education and Counseling 104 (2021) 1474–1480
Contents lists available at ScienceDirect
Patient Education and Counseling
journa l homepage: www.e l sev ier .com/ locate /pate ducou
dialysis type, residual kidney function, and hemoglobin level)
seem to explain dialysis patients’ HRQOL only to a limited extent
[10,12,13]. Cognitive-behavioral and social factors, on the other
hand, are known to have a considerable impact on HRQOL in
patients with a chronic illness [14].
The literature suggests several potential cognitive-behavioral
and social predictors of HRQOL in chronic illness. Cognitive-
behavioral factors involve general ways patients perceive and think
about their illness. For example, having a negative expectancy of
treatment outcome is found to have a negative effect on the course
and treatment success of a variety of medical conditions [15].
Negative outcome expectancies could be reflected in illness
cognitions, such as being able to accept the disease versus
experiencing a lack of control in handling the disease, which may
lead to feelings of helplessness regarding the disease and its
consequences [16,17]. Additionally, patients who tend to worry
about future outcomes frequently have both a lower HRQOL [18]
and more somatic symptoms [19]. Another potentially important
predictor of HRQOL is the patient’s confidence in its ability to
handle potential stressors, known as self-efficacy [20–23]. In
addition to these cognitive-behavioral factors, social aspects have
been found to affect HRQOL in patients with various chronic
diseases [24]. Social support serves as a buffer to stressors and
protects against unfavorable disease outcomes [14] and is
associated with better HRQOL and decreased somatic symptoms
and worrying [19,22,25–27]. Although the positive consequences
of social support have been shown rather consistently, hardly
any research in chronic somatic populations has been conducted
on the potential consequences of (deficits in) social skills of
patients. An example of this is being excessively aware of other
people’s behavior and feelings, defined as interpersonal sensitivity
[28,29].
The importance of these cognitive-behavioral and social factors
has been demonstrated before; however, there remains a clear
need for a thorough examination of multiple cognitive-behavioral
and social factors in dialysis patients. Especially with regard to
negative outcome expectancies, little work has been done to asses
if and how outcome expectancies relate to treatment outcome in
dialysis patients.
The objective of the current study is to determine which
cognitive-behavioral and social factors are relevant for HRQOL and
HRQOL changes in dialysis patients, after taking into account
demographic and clinical characteristics. It is expected that factors
related to negative outcome expectancies (higher levels of
helplessness and worrying and lower levels of self-efficacy) will
be associated with lower HRQOL. In addition, we expect lower
levels of illness acceptance and social support and higher levels of
interpersonal sensitivity to be associated with lower HRQOL. By
examining a broad range of factors, this study may provide
concrete indications for screening and interventions for improving
HRQOL in dialysis patients.
2. Methods
2.1. Participants and procedure
During the data collection period (2013–2015), hemodialysis
and peritoneal dialysis patients from multiple Dutch hospitals
(Radboud University Medical Center, VieCuri medical center,
Jeroen Bosch Hospital, Ravenstein Dialysis Centre, Bernhoven
Hospital, Canisius Wilhelmina Hospital) were screened for
participation. Exclusion criteria were: not being fluent in the
Dutch language, life expectancy <6 months, psychiatric problems,
recent major life events, and cognitive problems. After signing
informed consent, patients completed questionnaires at baseline
and at six months follow-up.
The Ethics Committee of the Radboud University Medical
Center decided that the study did not fall within the scope of the
Medical Research Involving Human Subjects Act, because of the
observational nature of the study in which no action or behavior
was imposed on the participants. Based on the validity of the
scientific research questions, the methodology, the safety and
privacy of the participants, they had no objections against the
conduct of the study. In all participating centers, the executive
board approved the study. The research was conducted in
accordance with the Helsinki Declaration.
2.2. Measures
2.2.1. Demographic and clinical characteristics
Demographic and clinical characteristics were assessed with
a general checklist and extracted from medical files. The
Charlson Comorbidity Index was determined by a trained nurse
specialist (RJ), with higher scores indicating a higher level of
comorbidity.
2.2.2. Physical and mental HRQOL
The RAND Short Form-36 Health Status Inventory (RAND SF-
36) [30] was used to measure HRQOL at baseline and 6 months
follow-up. The RAND SF-36 contains 36 items that can be
summarized into two composite scores: physical health and
mental health, with higher scores indicating better HRQOL.
The Hays norm-based scoring algorithm was applied, trans-
forming raw scores into T-scores (M = 50  10 in the general
population) [30]. In this sample, the internal consistencies
were good (physical health composite: α = 0.91 and 0.93; mental
health composite: α = 0.86 and 0.90 at baseline and follow-up,
respectively).
2.2.3. Cognitive-behavioral factors
2.2.3.1. Negative outcome expectancies. The subscale Helplessness
of the Illness Cognition Questionnaire (ICQ) [16] was used to
assess helplessness. This subscale contains 6 items, with higher
scores indicating a higher level of helplessness (Cronbach’s
α = 0.87). The Penn State Worry Questionnaire (PSWQ) [31] was
used to measure worrying. The PSWQ contains 16 items. Higher
scores indicate a stronger tendency to worry (Cronbach’s α = 0.91).
The Generalized Self-Efficacy Scale (GSES) [32] was used to assess
self-efficacy. The GSES consists of 10 items, with higher scores
indicating a greater generalized sense of self-efficacy (Cronbach’s
α = 0.86).
2.2.3.2. Acceptance. The subscale Acceptance of the Illness
Cognition Questionnaire (ICQ) [16] was used to assess
illness acceptance. This subscale consists of 6 items, with higher
scores indicating a higher level of acceptance (Cronbach’s α = 0.91).
2.2.4. Social factors
2.2.4.1. Social support. The Perceived Support subscale of the
Inventory of Social Reliance (ISR) [33] was used to measure
perceived support. This subscale contains 5 items, with higher
scores indicating a higher level of perceived support (Cronbach’s
α = 0.89).
2.2.4.2. Interpersonal sensitivity. The Interpersonal Awareness
subscale of the Interpersonal Sensitivity Measure (IPSM) [34]
was used to assess sensitivity to personal interactions. This
subscale contains 7 items, with higher scores indicating a stronger
sense of interpersonal sensitivity in social contexts (Cronbach’s
α = 0.80).
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2.3. Statistical analyses
First, the descriptives of the demographic, clinical, HRQOL,
cognitive-behavioral, and social variables were calculated.
Second, zero-order correlations between the demographic and
clinical variables on the one hand and HRQOL on the other hand
were calculated in order to examine which demographic and
clinical variables should be controlled for in further analyses.
Associations with categorical variables were examined with t-tests
and ANOVAs.
Third, zero-order correlations between possible predictor vari-
ables (i.e., cognitive-behavioral and social variables) and HRQOL
were calculated in order to examine the potential individual
contribution of these variables. These analyses were repeated while
controlling for baseline HRQOL to examine the association of the
individual variables with changes in HRQOL over time.
Fourth, to examine the relative contribution of the predictor
variables, hierarchical regression analyses were performed while
entering the variables showing significant zero-order correlations
with HRQOL. Demographic and clinical variables were entered in the
first block, followed by the cognitive-behavioral predictors in
the second block, and the social predictors in the third block. To
examine which predictors were associated with changes in HRQOL
over time, analyses were repeated while entering baseline HRQOL in
the second block preceding the cognitive-behavioral (3rd block) and
social (4th block) predictors. Correlation and regression coefficients
above 0.10, 0.30, and 0.50 were interpreted as small, medium, and
large, respectively [35]. Due to incidental missing values, sample size
varies per analysis. The lowest sample size was 83.




In total, 365 patients were screened for participation of which
95 were excluded based on our exclusion criteria. Of the remaining
270 patients, 175 patients completed the baseline questionnaires
(response rate 65 %) and 130 patients completed the follow-up
questionnaires. Patients who either were excluded or otherwise
decided not to participate did not differ in sex, age, or dialysis type
compared to participating patients. Also, no differences in any
study variables were found between patients who completed both
measurements and patients who completed only the baseline
measurement.
Baseline demographic and clinical characteristics of the 130
participants who completed both measurements are shown in
Table 1. Participants’ mean age was 69  14 years (range, 28–90),
57 % were male, and 61 % had a secondary-level education. Most
patients were treated with center hemodialysis (79 %), followed by
home hemodialysis (11 %) and peritoneal dialysis (10 %). Mean
dialysis duration was 58  56 months (range, 5–287), mean
albumin level was 33.6  3.9 g/L (range, 20.0-–42.0), and the mean
Charlson Comorbidity Index was 5.5 1.6 (range, 2.0–9.0). Most
reported comorbidities involved cardiovascular diseases, pulmo-
nary diseases, and diabetes type II.
3.2. HRQOL and cognitive-behavioral and social factors
Means and standard deviations of HRQOL and cognitive-
behavioral and social factors can be found in Table 1. Patients’
mean physical and mental HRQOL did not significantly differ
between baseline and follow-up (physical HRQOL: 36.6  10.3 and
35.6  11.1; p=0.44; mental HRQOL: 45.3  10.0 and 44.5  11.3;
p=0.33).
3.3. Associations of demographic and clinical characteristics with
HRQOL at six months follow-up
In comparison to women, men scored higher on physical
HRQOL (32.0  11.2 versus 38.4  10.3; p=0.003). Age, education
level, marital status, and employment status were not found to be
associated with HRQOL.
Higher Charlson comorbidity scores were associated with lower
physical (r=0.25; p = 0.02) and mental HRQOL (r=0.20; p = 0.04).
Dialysis type and albumin level were not related to HRQOL.
Resultantly, for the subsequent analyses, we adjusted for sex
and the Charlson Comorbidity Index.
3.4. Associations of cognitive-behavioral and social factors with
HRQOL
Partial correlations of physical and mental HRQOL at six months
follow-up with HRQOL and cognitive-behavioral and social factors
at baseline, while controlling for sex and the Charlson Comorbidity
Table 1




Age, years 68.9  13.8
Male sex 74 (56.9 %)
Education level
Primary 25 (19.2 %)
Secondary 79 (60.8 %)
Tertiary 18 (13.8 %)
Unknown 8 (6.2 %)
Marital status
With partner 73 (56.2 %)
No partner 51 (39.2 %)
Unknown 6 (4.6 %)
Employment status
Employed
Paid 10 (7.7 %)
Unpaid/volunteer 4 (3.1 %)
Unemployed
Retired 69 (53.1 %)
Other (e.g., domestic work, unemployment insurance) 31 (23.8 %)
Unknown 16 (12.3 %)
Clinical
Type of dialysis
Centre hemodialysis (day/night) 103 (79.2 %)
Home hemodialysis 14 (10.8 %)
Peritoneal dialysis 13 (10.0 %)
Dialysis duration, months 58  56
Albumin, g/L 33.6  3.9
Charlson score 5.5  1.6
Comorbidity






Physical health composite score (RAND SF-36; T-scores) 36.3  10.3
Mental health composite score (RAND SF-36; T-scores) 45.3  10.0
Cognitive-behavioral factors
Helplessness (ICQ) 13.8  4.6
Acceptance (ICQ) 18.3  4.8
Worrying (PSWQ) 39.2  9.9
Self-efficacy (GSES) 31.2  5.0
Social factors
Perceived support (ISR) 15.9  3.7
Interpersonal awareness (IPSM) 12.3  3.5
Notes: n = 130.
Categorical data expressed as count (percentage); continuous data as mean 
standard deviation.
HRQOL = health-related quality of life; RAND SF-36 = RAND Short Form-36 Health
Status Inventory; ICQ = Illness Cognition Questionnaire; PSWQ = Penn State Worry
Questionnaire; GSES = Generalized Self-Efficacy Scale; ISR = Inventory of Social
Reliance; IPSM = Interpersonal Sensitivity Measure.
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Index, are shown in Table 2. More helplessness was strongly
related to worse physical HRQOL six months later. Lower levels of
acceptance and higher levels of worrying were moderately related
to worse physical HRQOL. After controlling for baseline physical
HRQOL, small correlations with helplessness and worrying
remained significant.
More worrying was strongly related to worse mental HRQOL six
months later. Lower levels of acceptance and self-efficacy and
higher levels of helplessness and interpersonal awareness were
moderately related to a lower mental HRQOL. A lower level of
perceived support was slightly related to worse mental HRQOL.
After controlling for baseline mental HRQOL, small correlations of
worrying and interpersonal awareness with mental HRQOL at six
months remained significant.
3.5. Regression analyses
Table 3 presents the results of multiple regression analyses with
physical and mental HRQOL at six months follow-up as outcome
measure and demographic, clinical, and cognitive-behavioral and
social factors as predictive factors. All analyses included only those
variables that correlated significantly with either physical or
mental HRQOL at follow-up.
3.5.1. Physical HRQOL
Demographic and clinical variables explained 17.0 % of the
variance in physical HRQOL at six months (p<0.001), with female
sex being related to lower physical HRQOL. Adding the cognitive-
behavioral factors in block 2 resulted in a total of 41.3 % of the
explained variance of the model (p< 0.001), with higher levels of
helplessness at baseline being related to lower physical HRQOL six
months later. The other cognitive-behavioral factors were not
found to be significant (p-values  0.64). The social factors added
in block 3 did not significantly add to the model (p=0.38).
To examine whether the predictor variables accounted for a
change in physical HRQOL, we repeated the multiple regression
analyses while controlling for baseline physical HRQOL. Sex and
Charlson score were independently not significantly related to
physical HRQOL, but together explained a significant 15.7 % of the
variance (p=0.001). In block 2, adding baseline physical HRQOL
Table 2
Correlation coefficients of HRQOL at six months (T2) with HRQOL and cognitive-behavioral and social factors at baseline (T1) when controlled for sex and the Charlson
Comorbidity Index.










Physical HRQOL (T1) 0.81*** – – –
Mental HRQOL (T1) – – 0.70*** –
Cognitive-behavioral factors
Helplessness 0.61*** 0.29** 0.48*** 0.08
Acceptance 0.36*** 0.16 0.45*** 0.13
Worrying 0.31** 0.24* 0.53*** 0.28**
Self-efficacy 0.20 0.01 0.33** 0.08
Social factors
Perceived support 0.17 0.08 0.29** 0.18
Interpersonal awareness 0.20 0.02 0.38*** 0.21*
*p<.05; **p<.01;***p<.001.
Comparison in patients who completed both measurements; an = 90; bn = 89; cn = 97; dn = 94.
T1 = baseline; T2 = six months follow-up; HRQOL = health-related quality of life.
Table 3













Demographic and clinical factors
Sex 0.24** 0.04 0.08 0.07
Charlson score 0.10 0.05 0.05 0.07
Baseline HRQOL
Physical HRQOL – 0.65*** – –
Mental HRQOL – – – 0.52***
Cognitive-behavioural factors
Helplessness 0.45*** 0.23* 0.29** 0.20*
Acceptance 0.05 0.002 0.05 0.03
Worrying 0.05 0.01 0.28** 0.16
Self-efficacy 0.004 0.05 0.07 0.004
Social factors
Perceived support 0.12 0.02 0.23* 0.15
Interpersonal awareness 0.05 0.01 0.06 0.03
Total R2 0.43 0.67 0.42 0.57
HRQOL = health-related quality of life; β = standardized coefficients.
*p<.05; **p<.01;***p<.001.
a n = 88, R2 = 0.17 for block 1, DR2 = .24 for block 2, DR2 = 0.01 for block 3.
b n = 83, R2 = 0.16 for block 1, DR2 = .48 for block 2, DR2 = .03 for block 3, DR2<.001 for block 4.
c n = 94, R2 = .07 for block 1, DR2 = .30 for block 2, DR2 = 0.05 for block 3.
d n = 86, R2 = 0.05 for block 1, DR2 = .46 for block 2, DR2 = 0.04 for block 3, DR2 = 0.02 for block 4.
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resulted in a total explained variance of 63.8 % (p<0.001), with
lower physical HRQOL at baseline strongly predicting lower
physical HRQOL at six months follow-up. In block 3, adding the
cognitive-behavioral factors explained a total of 67.1 % of the
variance (p=0.12), with higher levels of helplessness predicting a
larger decrease in physical HRQOL six months later. The other
cognitive-behavioral factors were not found to be significant (p-
values  0.50). The social factors added in block 4 did not
significantly add to the model (p=.97).
3.5.2. Mental HRQOL
Sex and Charlson score were independently not significantly
related to mental HRQOL, but together explained a significant 7.3 %
of the variance (p=0.03). Adding the cognitive-behavioral factors
resulted in a total explained variance of 37.3 % (p<0.001), with
higher levels of helplessness and worrying being related to lower
mental HRQOL six months later. The other cognitive-behavioral
factors were not found to be significant (p-values  0.46). In block
3, adding the social factors resulted in a total of 42.3 % explained
variance (p=0.03), with lower levels of perceived support being
related to lower mental HRQOL. Interpersonal awareness was not
found to be significant (p=0.51).
Including baseline mental HRQOL, the demographic and clinical
variables explained a non-significant 5.4 % of the variance (p=0.10).
In block 2, adding baseline mental HRQOL explained 51.0 % of the
total variance (p<0.001), with lower mental HRQOL being
predictive of lower mental HRQOL at follow-up. Cognitive-
behavioral factors entered in block 3 resulted in a total explained
variance of 54.9 % (p=0.16), with higher levels of helplessness being
predictive of a larger decrease in mental HRQOL six months later.
The other cognitive-behavioral factors were not found to be
significant (p-values  0.12). Adding the social factors in block 4 did
not significantly add to the model (p=0.17).
4. Discussion
4.1. Discussion
Patients’ lives consist of more than just the disease they have. If
we truly want to improve patients’ quality of life, we should not
only focus on patients’ physical functioning but also on their
psychological and social well-being. This study found that patients’
feelings and thoughts regarding their disease are significantly
associated with HRQOL and, as a result, may be of essential
importance in improving HRQOL. Adopting realistic and adaptive
feelings and thoughts in addition to establishing a strong social
support system is recommended for patients to achieve a life as
normal and as comfortable as possible, despite the unalterable
consequences of their disease.
Mean HRQOL scores were similar to those found in two Dutch
cohort studies focusing on dialysis patients [11] and were one to
two standard deviations lower compared to the general population
[36]. These low HRQOL scores were relatively stable over the
course of the study: baseline HRQOL was found to be the strongest
predictor of HRQOL six months later. Patients’ low HRQOL will
largely be the direct result of the high disease burden and intrusive
dialysis treatment, and will, therefore, be hard to change directly.
However, identification of factors that influence HRQOL could help
improving HRQOL in a more indirect way.
We observed a clear relation between HRQOL and the negative
outcome expectancy-related constructs of helplessness and
worrying, both reflecting a negative outlook on the future. These
findings are in line with accumulating evidence underscoring the
relevance of outcome expectancies for quality of life and treatment
outcome in patients with a variety of somatic diseases. Moreover,
the way patients perceive and think about their illness influences
physical and mental outcome [16,37]. Expecting positive treat-
ment outcomes leads, for instance, to substantial improvements in
quality of life and relief of pain [15,38,39]. With regard to dialysis
patients, personal beliefs concerning the effectiveness of treat-
ment are even suggested to be predictive of survival [40,41].
However, little work has been carried out to study the role of
negative outcome expectancies in dialysis patients, making this
study one of the first. In our study, feelings of helplessness clearly
emerged as the strongest and most consistent predictor of both
physical and mental HRQOL, also being the only factor predicting a
worsening of HRQOL over time. To some degree, worrying also
uniquely added to patients’ mental HRQOL, which was in line with
previous studies linking worrying to increased emotional distress
in patients with chronic disease [42] and to increased somatic
symptoms [19] and worse HRQOL in ESkD [18]. Other studied
cognitive-behavioral factors, such as acceptance and self-efficacy
showed a significant association with HRQOL at six months follow-
up but did not predict a change of HRQOL over time.
Social factors showed to have additional value in predicting
future HRQOL in dialysis patients on top of the cognitive-
behavioral factors. More perceived support and less interpersonal
sensitivity were significantly related to a better mental HRQOL
after six months, although both did not independently predict a
change in HRQOL over time. The associations between social
factors and mental HRQOL are in line with previous research
showing that being excessively aware of the way one is perceived is
linked to anxiety and depression [28,29] and with the theory and
previous findings that social support could protect against
psychological distress in patients with chronic disease [14,43].
A specific strength of this study is the multivariate analysis with
the inclusion of a broad range of possible predictive cognitive-
behavioral and social factors while taking into account the effects
of demographic and clinical characteristics. In addition, assessing
HRQOL at baseline and six months follow-up provided the
opportunity to detect possible changes over time.
A limitation of our study is the relatively small sample size in light
of the amount of predictors we examined and the 25 % drop-out
across the six month assessment period. Nonetheless, adequate care
was taken to maintainsufficient power for the regression analyses by
including only those variables that showed a significant correlation
with HRQOL. Reasons for drop-out were not acquired but were
probably related to death, the high disease burden, and patients
receiving a kidney transplant during the course of the study. Another
limitation was the design of our study, which prevented us from
assessing causal relations. However, the prospective design did
enable us to address changes in HRQOL over time.
4.2. Conclusion
In this study, we assessed multiple possible predictors for
HRQOL, including cognitive-behavioral factors, incorporating
potentially relevant negative outcome expectancies, and social
factors. Although the importance of these factors has been
demonstrated before, only few studies have addressed the role
of this broad range of factors for dialysis patients.
In conclusion, we found that factors related to negative
outcome expectancies, especially helplessness and worrying,
and less perceived support were related to worse HRQOL six
months later. Additionally, helplessness was independently
associated with changes in HRQOL over time, on top of
demographic and clinical characteristics.
4.3. Practice implications
Although an experimental design is needed to confirm
causality, our results provide some practical suggestions to
J. Tommel et al. Patient Education and Counseling 104 (2021) 1474–1480
1478
improve HRQOL in dialysis patients. First, health care professionals
should be educated on the role of negative outcome expectancies
and supportive social interactions in treatment outcome and
HRQOL [44].
Second, health care professionals can implement several
strategies to prevent or reduce negative outcome expectancies.
Patient expectations can, for example, be managed by providing
enhanced treatment information [45,46]. In addition to informa-
tion on patients’ treatment and its consequences, this could
include psychoeducation on the effect of negative outcome
expectancies [44,47]. Additionally, an improved patient-clinician
relationship and an empathic communication style that promotes
mutual understanding, trust, and reassurance is found to be
effective in preventing negative outcome expectancies [45,48]. By
means of these processes, positive expectations are promoted and
health outcomes are found to improve [45,48–50]. Lastly, existing
negative outcome expectancies could be addressed by changing
any unrealistic, maladaptive expectations into more adaptive and
realistic expectations. This starts with regular screenings to
recognize patients with a vulnerability for negative outcome
expectancies, followed by specific interventions to support these
patients. Expectation-focused psychological interventions (EFPIs),
for example, have shown to be effective for both regular treatment
of chronic disease (e.g., coronary heart disease, cancer, and chronic
pain) and optimization of specific medical interventions such as a
scheduled surgery [15]. Cognitive-behavioral therapy (CBT) is
another effective approach in addressing patient expectations and
improving HRQOL in chronic disease patients [14], including
dialysis patients [51,52].
Third, as social support also was related to future HRQOL on top
of demographic and clinical characteristics, it could be relevant if
health care professionals could pay attention to a patient’s support
system. In case a lack of social support is noted, patients could be
attended to the presence of group- and individual-based CBT as
well as social support groups, which have been found to be
effective in strengthening the social support system and improving
social skills in dialysis patients [53,54].
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